A phase lb study of ribociclib in combination with doxorubicin in advanced soft tissue sarcomas (aSTS).

被引：0
|
作者：
Davis, Lara E.
Latour, Emile
Burch, Reid
Park, Byung
Davis, Jessica L.
Ryan, Christopher W.
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[2] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11548
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Phase II study of docetaxel in advanced soft tissue sarcomas
    Edmonson, JH
    Ebbert, LP
    Nascimento, AG
    Jung, SH
    McGaw, H
    Gerstner, JB
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1996, 19 (06): : 574 - 576
  • [12] METASTATIC PATTERNS OF ADULT SOFT-TISSUE SARCOMAS (ASTS)
    KAVANAGH, J
    YAP, B
    LUNA, M
    TASHIMA, C
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 480 - 480
  • [13] PHASE-II STUDY OF A COMBINATION OF MITOMYCIN, DOXORUBICIN AND CISPLATIN IN ADVANCED SARCOMAS
    EDMONSON, JH
    LONG, HJ
    RICHARDSON, RL
    CREAGAN, ET
    GREEN, SJ
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1985, 15 (02) : 181 - 182
  • [14] SURVIVAL AND RELAPSE PATTERNS OF COMPLETE RESPONDERS IN ADULTS WITH ADVANCED SOFT-TISSUE SARCOMAS (ASTS)
    YAP, BS
    SINKOVICS, JG
    BENJAMIN, RS
    BODEY, GP
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 352 - 352
  • [15] Doxorubicin and Olaratumab Versus Doxorubicin, Ifosfamide, and Mesna for Treatment of Advanced Soft Tissue Sarcomas
    Hammer, Kathryn J.
    Copeland, Vanessa C.
    Loggers, Elizabeth T.
    Pollack, Seth M.
    Wagner, Michael J.
    Cranmer, Lee D.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2020, 43 (06): : 446 - 451
  • [16] Liposomal Doxorubicin (Caelyx) in advanced pretreated Soft Tissue Sarcomas: A phase II study of the Italian Sarcoma Group (ISG)
    Toma, S
    Tucci, A
    Villani, G
    Carteni, G
    Spadini, N
    Palumbo, R
    ANTICANCER RESEARCH, 2000, 20 (1B) : 485 - 491
  • [17] Pegylated liposomal doxorubicin combined with ifosfamide for advanced soft tissue sarcomas: A phase I dose-escalation study
    Ye, Ting
    Fan, Li
    Cao, Rubo
    Peng, Ling
    Chen, Jing
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [18] Phase II study of raltitrexed ('Tomudex') for patients with advanced soft tissue sarcomas refractory to doxorubicin-containing regimens
    Blay, JY
    Judson, I
    Rodenhuis, S
    Hermans, C
    Smith, M
    van Glabbeke, M
    Verweij, J
    ANTI-CANCER DRUGS, 1999, 10 (10) : 873 - 877
  • [19] Phase II study of doxorubicin and bevacizumab for patients with metastatic soft-tissue sarcomas
    D'Adamo, DR
    Anderson, SE
    Albritton, K
    Yamada, J
    Riedel, E
    Scheu, K
    Schwartz, GK
    Chen, H
    Maki, RG
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (28) : 7135 - 7142
  • [20] Gemcitabine in combination with paclitaxel for advanced soft-tissue sarcomas
    Sonnenblick, Amir
    Eleyan, Feras
    Peretz, Tamar
    Ospovat, Inna
    Merimsky, Ofer
    Sella, Tamar
    Peylan-Ramu, Nili
    Katz, Daniela
    MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (04) : 829 - 832
12345